Month: April 2024

Majority of women in states with abortion bans believe access should be legal

"Nearly two years after the Supreme Court ended the federal right to abortion, more than a fifth of reproductive-age adult women in states with abortion bans have struggled to access abortion care themselves or know someone who has, according to first-of-its-kind polling released Friday by the nonprofit, nonpartisan health policy research group KFF. A majority of these women — 67 percent — believe that abortion should be legal in all or most cases, according to the survey taken February 20-28, 2024...."
Read More

One in Five Women of Reproductive Age in States with Abortion Bans Say They or Someone They Know Has Had Difficulty Accessing an Abortion Since Dobbs

According to new KFF polling, in states with abortion bans, one in five (21%) women of reproductive age (18 to 49) and one in seven (14%) of all women say either they or someone they know has had difficulty accessing an abortion since the Supreme Court overturned Roe v. Wade.
Read More

Arizona organizers say they have more than enough signatures for an abortion ballot measure

"A group hoping to put an amendment enshrining the right to abortion in Arizona's constitution said Tuesday that they had gathered enough signatures for the measure to qualify for the ballot in November. There is a requirement for the collection of 383,923 signatures of support for constitutional amendments in Arizona, and Dawn Penich, communications manager for Arizona for Abortion Access, said they have amassed more than 500,000 signatures already..."
Read More

Supreme Court Skeptical of Push to Curb Access to Abortion Pill

"In the 2022 case of Dobbs v. Jackson Women’s Health Organization, the U.S. Supreme Court overturned Roe v. Wade and held that there is no constitutional right to an abortion, returning the legality of abortion to the states. The court must now decide if access to mifepristone, the drug used in medication abortions, should be restricted. During oral arguments last week, most of the justices seemed reluctant to roll back access to the drug. Instead, they focused on whether the plaintiffs had a legal right, or standing, to sue and questioned whether the doctors in the case, Food and Drug Administration v. Alliance for…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.